Steven C. Katz's most recent trade in TriSalus Life Sciences Inc was a trade of 105,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 12, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
TriSalus Life Sciences Inc | Katz Steven C. | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 105,000 | 105,000 | - | - | Employee Stock Option (right to buy) | |
TriSalus Life Sciences Inc | Steven C. Katz | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 34,144 | 68,587 | - | 0 | Common Stock | |
TriSalus Life Sciences Inc | Steven C. Katz | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 62,500 | 62,500 | - | - | Employee Stock Option (right to buy) |